Xaira logo

Xaira Funding & Investors

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.

xaira.com

Total Amount Raised: $1,000,000,000

Xaira Funding Rounds

  • Series A

    $1,000,000,000

    Series A Investors

    Arch Venture Partners
    Foresite Capital
    Parker Institute for Cancer Immunotherapy
    Sequoia Capital
    Menlo Ventures
    New Enterprise Associates (NEA)
    Lightspeed Venture Partners
    Byers Capital
    R-Squared Ventures
    F-Prime Capital
    Two Sigma Ventures
    SV Angel
    Lux Capital
Funding info provided by Diffbot.